Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010829 · ClinicalTrials.gov registry record · Phase 2
Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00010829 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH).
The verdict
NCT00010829, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study will assess whether alternative, high phytoestrogen dietary interventions result in favorable effects on biological parameters that have been associated with hormone-dependent cancers, cardiovascular disease, and osteoporosis.
Interventions
- BEHAVIORAL American Heart Association Step 1 diet
- BEHAVIORAL American Heart Association Step 2 diet + 10 g/day flax seed
- BEHAVIORAL Macrobiotic dietary intervention
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-01 |
| Est. Completion | 2005-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00010829
The ClinicalTrials.gov registry entry for NCT00010829 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which American Heart Association Step 1 diet is the first listed.
NCT00010829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00010829 about?
NCT00010829 is a clinical study titled "Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors". This study will assess whether alternative, high phytoestrogen dietary interventions result in favorable effects on biological parameters that have been associated with hormone-dependent cancers, cardiovascular disease, and osteoporosis.
What is the current status of trial NCT00010829?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-01. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00010829?
The interventions under investigation include: American Heart Association Step 1 diet (BEHAVIORAL), American Heart Association Step 2 diet + 10 g/day flax seed (BEHAVIORAL), Macrobiotic dietary intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00010829?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.